Filing Details

Accession Number:
0001209191-13-023049
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-30 13:51:20
Reporting Period:
2013-04-29
Filing Date:
2013-04-30
Accepted Time:
2013-04-30 13:51:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
742112 Invacare Corp IVC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 952680965
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
937770 Iii Malachi Aaron Mixon One Invacare Way
Elyria OH 44035
Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2013-04-29 22,850 $12.53 342,546 No 4 P Direct
Common Shares Acquisiton 2013-04-29 22,850 $12.53 85,444 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 69,446 Indirect By GRAT
Common Shares 12,289 Indirect By GRAT
Common Shares 12,288 Indirect By GRAT
Common Shares 46,322 Indirect By GRAT
Common Shares 46,322 Indirect By GRAT
Common Shares 18,901 Indirect By Invacare Retirement Savings Plan
Class B Common Shares 2,003 Direct
Class B Common Shares 330,907 Indirect By GRAT
Class B Common Shares 261,461 Indirect By GRAT
Class B Common Shares 26,536 Indirect By GRAT
Class B Common Shares 83,005 Indirect By GRAT
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Employee Stock Option (Right to Buy) $0.00 1,092,200 1,092,200 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
1,092,200 1,092,200 Direct
Footnotes
  1. Price reported constitutes the weighted average price of shares purchased. Shares were purchased in multiple transactions at prices ranging from $12.23 - $12.57. The reporting person hereby undertakes upon request of the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  2. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  3. Owned by the Trustee for the 2012 Grantor Retained Annuity Trust created by the reporting person's spouse.
  4. Owned by the Trustee for the 1997 Grantor Retained Annuity Trust created by the reporting person's spouse.
  5. Owned by the Trustee for the 1997 Grantor Retained Annuity Trust created by the reporting person.
  6. Owned by the Trustee for the 2009 Grantor Retained Annuity Trust created by the reporting person.
  7. On February 2, 2013, the grantor retained annuity trust made an annuity payment of 48,925 Common Shares to the reporting person.
  8. Owned by the Trustee for the 2009 Grantor Retained Annuity Trust created by the reporting person's spouse.
  9. On February 2, 2013, the grantor retained annuity trust made an annuity payment of 48,925 Common Shares to the reporting person's spouse.
  10. Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2012, the most recent information reasonably available.
  11. Owned by the Trustee for the 2012 Grantor Retained Annuity Trust created by the reporting person.
  12. Owned by the Trustee for the 2011 Grantor Retained Annuity Trust created by the reporting person.
  13. Owned by the Trustee for the 2011 Grantor Retained Annuity Trust created by the reporting person's spouse.
  14. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
  15. The reporting person holds previously reported options to buy 1,092,200 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 20, 2003 and March 18, 2013, at exercise prices between $13.37 to $44.30 per share, will expire between August 20, 2013 and March 18, 2023 and became or will become exercisable between September 30, 2004 and March 31, 2017.